The total return over the past 12 months is +160.60% vs. +16.94% for the S&P 500. So far it's up +267.81% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +160.60% | +129.78% | +19.76% | +23.22% | N/A | N/A |
| Total Return CAGR | +160.60% | +129.78% | +19.76% | +23.22% | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Pulse Biosciences, Inc. (PLSE)
| Year | Start price | End price | PLSE Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $13.73 | $50.50 | +267.81% | +14.51% | +253.30% |
| 2025 | $17.41 | $13.73 | (21.14%) | +17.72% | (38.86%) |
| 2024 | $12.24 | $17.41 | +42.24% | +24.89% | +17.35% |
| 2023 | $2.77 | $12.24 | +341.88% | +26.19% | +315.69% |
| 2022 | $14.81 | $2.77 | (81.30%) | (18.17%) | (63.13%) |
| 2021 | $23.86 | $14.81 | (37.93%) | +28.74% | (66.67%) |
| 2020 | $13.41 | $23.86 | +77.93% | +18.37% | +59.56% |
| 2019 | $11.46 | $13.41 | +17.02% | +31.22% | (14.20%) |
| 2018 | $23.60 | $11.46 | (51.44%) | (4.56%) | (46.88%) |
| 2017 | $6.50 | $23.60 | +263.08% | +21.70% | +241.38% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
